You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 31, 2024

List of Excipients in API CLOTRIMAZOLE


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing CLOTRIMAZOLE

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Walgreen Company WALGREENS clotrimazole 0363-2062 BENZYL ALCOHOL
Walgreen Company WALGREENS clotrimazole 0363-2062 CETOSTEARYL ALCOHOL
Walgreen Company WALGREENS clotrimazole 0363-2062 CETYL ESTERS WAX
Walgreen Company WALGREENS clotrimazole 0363-2062 OCTYLDODECANOL
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for CLOTRIMAZOLE

Excipient focus: ALCOHOL

Excipient focus: BENZYL ALCOHOL

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CETEARETH-30

CLOTRIMAZOLE drug variants containing CETEARETH-30

Company Ingredient NDC
Merck Sharp & Dohme Corp clotrimazole and betamethasone dipropionate 0085-0924
E Fougera & Co a division of Fougera Pharmaceuticals Inc clotrimazole and betamethasone dipropionate 0168-0258
E Fougera & Co a division of Fougera Pharmaceuticals Inc clotrimazole and betamethasone dipropionate 0168-0370
Actavis Pharma Inc clotrimazole and betamethasone dipropionate 0472-0379
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: CETOSTEARYL ALCOHOL

Excipient focus: CETYL ALCOHOL

Excipient focus: CETYL ESTERS WAX

Excipient focus: CHLOROFORM

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: DEXTRATES

Excipient focus: DEXTROSE

Excipient focus: LIGHT MINERAL OIL

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MINERAL OIL

CLOTRIMAZOLE drug variants containing MINERAL OIL

Company Ingredient NDC
Merck Sharp & Dohme Corp clotrimazole and betamethasone dipropionate 0085-0924
E Fougera & Co a division of Fougera Pharmaceuticals Inc clotrimazole and betamethasone dipropionate 0168-0258
E Fougera & Co a division of Fougera Pharmaceuticals Inc clotrimazole and betamethasone dipropionate 0168-0370
Actavis Pharma Inc clotrimazole and betamethasone dipropionate 0472-0379
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: OCTYLDODECANOL

Excipient focus: OCTYLDODECYL STEARATE

Excipient focus: PETROLATUM

CLOTRIMAZOLE drug variants containing PETROLATUM

Company Ingredient NDC
Merck Sharp & Dohme Corp clotrimazole and betamethasone dipropionate 0085-0924
E Fougera & Co a division of Fougera Pharmaceuticals Inc clotrimazole and betamethasone dipropionate 0168-0258
E Fougera & Co a division of Fougera Pharmaceuticals Inc clotrimazole and betamethasone dipropionate 0168-0370
Actavis Pharma Inc clotrimazole and betamethasone dipropionate 0472-0379
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: PHOSPHORIC ACID

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYSORBATE 60

Excipient focus: POVIDONE

Excipient focus: POVIDONE K30

Excipient focus: PROPYLENE GLYCOL

CLOTRIMAZOLE drug variants containing PROPYLENE GLYCOL

Company Ingredient NDC
Merck Sharp & Dohme Corp clotrimazole and betamethasone dipropionate 0085-0924
E Fougera & Co a division of Fougera Pharmaceuticals Inc clotrimazole and betamethasone dipropionate 0168-0258
E Fougera & Co a division of Fougera Pharmaceuticals Inc clotrimazole and betamethasone dipropionate 0168-0370
Actavis Pharma Inc clotrimazole and betamethasone dipropionate 0472-0379
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM PHOSPHATE, MONOBASIC

CLOTRIMAZOLE drug variants containing SODIUM PHOSPHATE, MONOBASIC

Company Ingredient NDC
E Fougera & Co a division of Fougera Pharmaceuticals Inc clotrimazole and betamethasone dipropionate 0168-0258
Rebel Distributors Corp clotrimazole and betamethasone dipropionate 21695-333
Unit Dose Services clotrimazole and betamethasone dipropionate 50436-4546
RPK Pharmaceuticals Inc clotrimazole and betamethasone dipropionate 53002-9743
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS

Excipient focus: SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE

Excipient focus: SORBITAN

Excipient focus: SORBITAN MONOSTEARATE

Excipient focus: STEARYL ALCOHOL

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group